Associate Researcher, First Affiliated Hospital of Dalian Medical University, China
Dr. Hong Xiang is an accomplished researcher specializing in integrated medicine intervention for exocrine pancreatic diseases. With a strong track record of pioneering multi-omics platforms and 3D pancreatic organoid co-culture technologies, Dr. Xiang has contributed significantly to discovering new therapeutic targets and developing innovative peptide drugs and mRNA vaccines. He is a recognized member of several prestigious scientific societies, actively advancing pancreatic disease research.
Publication Profile
Scopus
ORCID
Education Background 🎓
Dr. Xiang holds advanced degrees in biomedical sciences and has undergone extensive training in multi-omics platforms and organoid technology, which form the foundation of his cutting-edge research in pancreatic diseases.
Professional Experience 💼
Currently engaged in cutting-edge research, Dr. Xiang has published 24 journal articles in top-tier SCI and Scopus-indexed journals, authored multiple patents (13), and contributed to several books. He holds memberships in notable professional bodies such as the American Pancreatic Association and Chinese Society of Inventions, reflecting his leadership in translational medicine and drug development.
Awards and Honors 🏆
Among his accolades, Dr. Xiang received the Dalian Science and Technology Talent Innovation Support Program Project award for Outstanding Young Science and Technology Talents (2022RY16). His innovative work in integrated medicine and pancreatic disease treatment continues to earn him recognition in academic and scientific communities.
Research Focus 🔬
Dr. Xiang’s primary research focus lies in integrated medicine for exocrine pancreatic diseases, with key discoveries targeting S100A9, RFTN1, and HTRA1 proteins implicated in pancreatitis and cancer transformation. His development of attenuated peptide drugs and mRNA vaccines highlights a promising therapeutic frontier in pancreatic oncology and inflammation.
Conclusion ✨
Dr. Hong Xiang exemplifies a leading figure in pancreatic disease research, merging innovative technology platforms with translational medicine. His contributions pave the way for novel therapies that can revolutionize treatment paradigms, securing his status as a deserving candidate for the Best Researcher Award.
Publication Top Notes 📚
-
Prospect of Gold Nanoparticles in Pancreatic Cancer
Pharmaceutics, 2024 | DOI:10.3390/pharmaceutics16060806
Co-authors: Tianyi Yin, Jingrun Han, Yuying Cui, Dong Shang, Hong Xiang
-
Vanin1 (VNN1) in chronic diseases: Future directions for targeted therapy
European Journal of Pharmacology, 2024 | DOI:10.1016/j.ejphar.2023.176220
Co-authors: Hao Yu, Yuying Cui, Fangyue Guo, YuTong Zhu, Xiaonan Zhang, Dong Shang, Deshi Dong, Hong Xiang
-
Carfilzomib relieves pancreatitis-initiated pancreatic ductal adenocarcinoma by inhibiting high-temperature requirement protein A1
Cell Death Discovery, 2024 | DOI:10.1038/s41420-024-01806-w
Co-authors: Fangyue Guo, Xufeng Tao, Yu Wu, Deshi Dong, Yanna Zhu, Dong Shang, Hong Xiang
-
Tryptophan metabolite norharman secreted by cultivated Lactobacillus attenuates acute pancreatitis as an antagonist of histone deacetylases
BMC Medicine, 2023 | DOI:10.1186/s12916-023-02997-2
Co-authors: Qi Zhou, Xufeng Tao, Fangyue Guo, Yu Wu, Dawei Deng, Linlin Lv, Deshi Dong, Dong Shang, Hong Xiang
-
Health Impacts of High BMI in China: Terrible Present and Future
International Journal of Environmental Research and Public Health, 2022 | DOI:10.3390/ijerph192316173
Co-authors: Hong Xiang, Runjuan Yang, Jiaxin Tu, Xi Guan, Xufeng Tao
-
Activated Pancreatic Stellate Cells Promote Acinar Duct Metaplasia by Disrupting Mitochondrial Respiration and Releasing Reactive Oxygen Species
Current Chinese Science, 2022 | DOI:10.2174/2210298101666210928122952
Co-authors: Hong Xiang, Fangyue Guo, Qi Zhou, Xufeng Tao, Deshi Dong
-
Bacterial community mapping of the intestinal tract in acute pancreatitis rats based on 16S rDNA gene sequence analysis
RSC Advances, 2019 | DOI:10.1039/C8RA09547G
Co-authors: Xufeng Tao, Fangyue Guo, Qi Zhou, Fenglin Hu, Hong Xiang, Gary Guishan Xiao, Dong Shang